Butterfly Network (BFLY) Competitors $1.60 -0.03 (-1.53%) As of 02:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BFLY vs. NVCR, SSII, CDRE, BLFS, ESTA, MDXG, PLSE, INMD, IRMD, and BBNXShould you be buying Butterfly Network stock or one of its competitors? The main competitors of Butterfly Network include NovoCure (NVCR), SS Innovations International (SSII), Cadre (CDRE), BioLife Solutions (BLFS), Establishment Labs (ESTA), MiMedx Group (MDXG), Pulse Biosciences (PLSE), InMode (INMD), iRadimed (IRMD), and Beta Bionics (BBNX). These companies are all part of the "medical equipment" industry. Butterfly Network vs. Its Competitors NovoCure SS Innovations International Cadre BioLife Solutions Establishment Labs MiMedx Group Pulse Biosciences InMode iRadimed Beta Bionics NovoCure (NASDAQ:NVCR) and Butterfly Network (NYSE:BFLY) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability. Does the media favor NVCR or BFLY? In the previous week, NovoCure had 7 more articles in the media than Butterfly Network. MarketBeat recorded 10 mentions for NovoCure and 3 mentions for Butterfly Network. Butterfly Network's average media sentiment score of 1.66 beat NovoCure's score of 0.93 indicating that Butterfly Network is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NovoCure 3 Very Positive mention(s) 4 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Butterfly Network 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders & institutionals hold more shares of NVCR or BFLY? 84.6% of NovoCure shares are held by institutional investors. Comparatively, 37.9% of Butterfly Network shares are held by institutional investors. 5.5% of NovoCure shares are held by insiders. Comparatively, 25.2% of Butterfly Network shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has better valuation and earnings, NVCR or BFLY? Butterfly Network has lower revenue, but higher earnings than NovoCure. NovoCure is trading at a lower price-to-earnings ratio than Butterfly Network, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNovoCure$605.22M2.32-$168.63M-$1.56-8.04Butterfly Network$82.06M4.92-$72.49M-$0.28-5.73 Is NVCR or BFLY more profitable? NovoCure has a net margin of -27.13% compared to Butterfly Network's net margin of -71.79%. Butterfly Network's return on equity of -30.53% beat NovoCure's return on equity.Company Net Margins Return on Equity Return on Assets NovoCure-27.13% -47.74% -13.79% Butterfly Network -71.79%-30.53%-21.80% Which has more risk & volatility, NVCR or BFLY? NovoCure has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Comparatively, Butterfly Network has a beta of 2.52, indicating that its share price is 152% more volatile than the S&P 500. Do analysts recommend NVCR or BFLY? NovoCure presently has a consensus price target of $28.79, indicating a potential upside of 129.51%. Butterfly Network has a consensus price target of $3.00, indicating a potential upside of 86.92%. Given NovoCure's higher possible upside, equities research analysts clearly believe NovoCure is more favorable than Butterfly Network.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NovoCure 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57Butterfly Network 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 SummaryButterfly Network beats NovoCure on 9 of the 16 factors compared between the two stocks. Get Butterfly Network News Delivered to You Automatically Sign up to receive the latest news and ratings for BFLY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BFLY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BFLY vs. The Competition Export to ExcelMetricButterfly NetworkMEDICAL INFO SYS IndustryMedical SectorNYSE ExchangeMarket Cap$409.08M$2.17B$5.75B$21.53BDividend YieldN/AN/A5.88%3.49%P/E Ratio-5.8037.4777.0130.00Price / Sales4.9210.47528.6551.62Price / CashN/A57.9937.2024.77Price / Book2.0311.3313.964.55Net Income-$72.49M-$64.84M$3.29B$999.02M7 Day Performance8.08%-0.43%1.38%2.11%1 Month Performance12.23%1.84%5.13%5.37%1 Year Performance-16.41%33.93%84.67%14.63% Butterfly Network Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BFLYButterfly Network3.3556 of 5 stars$1.61-1.5%$3.00+86.9%-10.7%$409.08M$82.06M-5.80460NVCRNovoCure4.2644 of 5 stars$12.60+2.6%$28.79+128.5%-29.4%$1.37B$605.22M-8.081,488Positive NewsGap UpSSIISS Innovations InternationalN/A$6.14-12.3%N/AN/A$1.36B$20.65M0.004News CoverageGap DownHigh Trading VolumeCDRECadre2.6874 of 5 stars$31.83-0.5%$31.50-1.0%-8.7%$1.30B$567.56M33.862,284Positive NewsBLFSBioLife Solutions2.5326 of 5 stars$26.22-0.9%$31.29+19.3%+2.0%$1.27B$82.25M-218.48440News CoverageESTAEstablishment Labs2.2587 of 5 stars$38.24-2.0%$56.50+47.8%-12.3%$1.13B$166.02M0.001,018Positive NewsMDXGMiMedx Group3.5004 of 5 stars$7.17+0.4%$12.00+67.4%+12.1%$1.06B$348.88M23.80870Positive NewsPLSEPulse Biosciences4.2453 of 5 stars$15.04-0.5%$22.00+46.3%-18.4%$1.02B$700K-14.32140News CoverageInsider TradeINMDInMode2.9858 of 5 stars$15.28+2.0%$18.04+18.1%-12.3%$946.87M$394.82M6.19480Positive NewsIRMDiRadimed4.8049 of 5 stars$71.85-0.2%$72.00+0.2%+45.7%$915.36M$73.24M44.35110Short Interest ↓BBNXBeta Bionics1.0564 of 5 stars$23.13+14.5%$22.56-2.5%N/A$878.10M$65.12M0.00294High Trading Volume Related Companies and Tools Related Companies NVCR Alternatives SSII Alternatives CDRE Alternatives BLFS Alternatives ESTA Alternatives MDXG Alternatives PLSE Alternatives INMD Alternatives IRMD Alternatives BBNX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BFLY) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Butterfly Network, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Butterfly Network With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.